ANGIOSARCOMA METASTATIC

ANGIOSARCOMA METASTATIC was reported 122 times

These drug classes are most commonly taken by patients reporting ANGIOSARCOMA METASTATIC:

# Drug Count
0 Corticosteroid [EPC] 50
1 Antimetabolite Immunosuppressant [EPC] 17
2 Kinase Inhibitor [EPC] 15
3 Microtubule Inhibitor [EPC] 13
4 Alkylating Drug [EPC] 9
5 Immunoglobulin G [EPC] 9
6 mTOR Inhibitor Immunosuppressant [EPC] 5
7 CD52-directed Cytolytic Antibody [EPC] 4
8 Janus Kinase Inhibitor [EPC] 4
9 Folate Analog Metabolic Inhibitor [EPC] 3
10 Nonsteroidal Anti-inflammatory Drug [EPC] 3
11 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2
12 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
13 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
14 Loop Diuretic [EPC] 2
15 Opioid Agonist [EPC] 2
16 RANK Ligand Inhibitor [EPC] 2
17 Xanthine Oxidase Inhibitor [EPC] 2
18 Aminosalicylate [EPC] 1
19 Angiotensin 2 Receptor Blocker [EPC] 1
20 Antifibrinolytic Agent [EPC] 1
21 Antirheumatic Agent [EPC] 1
22 CD20-directed Cytolytic Antibody [EPC] 1
23 Calcineurin Inhibitor Immunosuppressant [EPC] 1
24 Endothelin Receptor Antagonist [EPC] 1
25 GLP-1 Receptor Agonist [EPC] 1
26 HMG-CoA Reductase Inhibitor [EPC] 1
27 Insulin Analog [EPC] 1
28 Integrin Receptor Antagonist [EPC] 1
29 Interleukin-12 Antagonist [EPC] 1
30 Interleukin-23 Antagonist [EPC] 1
31 Interleukin-6 Receptor Antagonist [EPC] 1
32 Leukocyte Growth Factor [EPC] 1
33 Nucleoside Analog Antiviral [EPC] 1
34 Platelet Aggregation Inhibitor [EPC] 1
35 Platinum-based Drug [EPC] 1
36 Polyene Antifungal [EPC] 1
37 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
38 Provitamin D2 Compound [EPC] 1
39 Purine Antimetabolite [EPC] 1
40 Thrombopoietin Receptor Agonist [EPC] 1
41 Topoisomerase Inhibitor [EPC] 1
42 Tumor Necrosis Factor Blocker [EPC] 1
43 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
44 alpha-Glucosidase Inhibitor [EPC] 1